Abstract

Objective To investigate the clinical value of enhanced recovery after surgery (ERAS) in radical resection of primary liver cancer. Methods In this study 68 patients were randomly assigned into the ERAS group (n=35), and control group (n=33). Results Comparing with control group, there was significant differences in ERAS group with less volume of intraoperative intravenous fluid (t=2.812, P 0.05). Conclusion ERAS was safe and effective for patients undergoing radical resection of primary liver cancer. Key words: Carcinoma, hepatocellular; Hospital convalescent; Hepatectomy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call